The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceutical and Vaccines Market Research Report 2025
Synopsis
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
The global Biopharmaceutical and Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccines.
Report Scope
The Biopharmaceutical and Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical and Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Segment by Type
Biopharmaceutical
Vaccine Production
Segment by Application
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
The global Biopharmaceutical and Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccines.
Report Scope
The Biopharmaceutical and Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical and Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Segment by Type
Biopharmaceutical
Vaccine Production
Segment by Application
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biopharmaceutical
1.2.3 Vaccine Production
1.3 Market by Application
1.3.1 Global Biopharmaceutical and Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals Industry
1.3.3 Clinical Diagnosis
1.3.4 Scientific Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical and Vaccines Market Perspective (2019-2030)
2.2 Biopharmaceutical and Vaccines Growth Trends by Region
2.2.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical and Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical and Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical and Vaccines Market Dynamics
2.3.1 Biopharmaceutical and Vaccines Industry Trends
2.3.2 Biopharmaceutical and Vaccines Market Drivers
2.3.3 Biopharmaceutical and Vaccines Market Challenges
2.3.4 Biopharmaceutical and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical and Vaccines Players by Revenue
3.1.1 Global Top Biopharmaceutical and Vaccines Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical and Vaccines Revenue
3.4 Global Biopharmaceutical and Vaccines Market Concentration Ratio
3.4.1 Global Biopharmaceutical and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccines Revenue in 2023
3.5 Biopharmaceutical and Vaccines Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical and Vaccines Product Solution and Service
3.7 Date of Enter into Biopharmaceutical and Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical and Vaccines Breakdown Data by Type
4.1 Global Biopharmaceutical and Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical and Vaccines Breakdown Data by Application
5.1 Global Biopharmaceutical and Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical and Vaccines Market Size (2019-2030)
6.2 North America Biopharmaceutical and Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceutical and Vaccines Market Size by Country (2019-2024)
6.4 North America Biopharmaceutical and Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical and Vaccines Market Size (2019-2030)
7.2 Europe Biopharmaceutical and Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceutical and Vaccines Market Size by Country (2019-2024)
7.4 Europe Biopharmaceutical and Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceutical and Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical and Vaccines Market Size (2019-2030)
9.2 Latin America Biopharmaceutical and Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceutical and Vaccines Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceutical and Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceutical and Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Biopharmaceutical and Vaccines Introduction
11.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Biopharmaceutical and Vaccines Introduction
11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Biopharmaceutical and Vaccines Introduction
11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Biopharmaceutical and Vaccines Introduction
11.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Biopharmaceutical and Vaccines Introduction
11.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Detail
11.6.2 Biogen Idec Business Overview
11.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction
11.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.6.5 Biogen Idec Recent Development
11.7 Regeneron Pharmaceuticals
11.7.1 Regeneron Pharmaceuticals Company Detail
11.7.2 Regeneron Pharmaceuticals Business Overview
11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction
11.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.7.5 Regeneron Pharmaceuticals Recent Development
11.8 Alexion Pharmaceuticals
11.8.1 Alexion Pharmaceuticals Company Detail
11.8.2 Alexion Pharmaceuticals Business Overview
11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction
11.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.8.5 Alexion Pharmaceuticals Recent Development
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Detail
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction
11.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.9.5 Johnson and Johnson Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction
11.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.10.5 GlaxoSmithKline Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Biopharmaceutical and Vaccines Introduction
11.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Lonza
11.12.1 Lonza Company Detail
11.12.2 Lonza Business Overview
11.12.3 Lonza Biopharmaceutical and Vaccines Introduction
11.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.12.5 Lonza Recent Development
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Detail
11.13.2 Boehringer Ingelheim Business Overview
11.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction
11.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.13.5 Boehringer Ingelheim Recent Development
11.14 Rentschler
11.14.1 Rentschler Company Detail
11.14.2 Rentschler Business Overview
11.14.3 Rentschler Biopharmaceutical and Vaccines Introduction
11.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2019-2024)
11.14.5 Rentschler Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biopharmaceutical
Table 3. Key Players of Vaccine Production
Table 4. Global Biopharmaceutical and Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Biopharmaceutical and Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biopharmaceutical and Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Biopharmaceutical and Vaccines Market Share by Region (2019-2024)
Table 8. Global Biopharmaceutical and Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Biopharmaceutical and Vaccines Market Share by Region (2025-2030)
Table 10. Biopharmaceutical and Vaccines Market Trends
Table 11. Biopharmaceutical and Vaccines Market Drivers
Table 12. Biopharmaceutical and Vaccines Market Challenges
Table 13. Biopharmaceutical and Vaccines Market Restraints
Table 14. Global Biopharmaceutical and Vaccines Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Biopharmaceutical and Vaccines Market Share by Players (2019-2024)
Table 16. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccines as of 2023)
Table 17. Ranking of Global Top Biopharmaceutical and Vaccines Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccines Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biopharmaceutical and Vaccines Product Solution and Service
Table 21. Date of Enter into Biopharmaceutical and Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical and Vaccines Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2019-2024)
Table 25. Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2025-2030)
Table 27. Global Biopharmaceutical and Vaccines Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2019-2024)
Table 29. Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2025-2030)
Table 31. North America Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Biopharmaceutical and Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Biopharmaceutical and Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Biopharmaceutical and Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Biopharmaceutical and Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical and Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Biopharmaceutical and Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Biopharmaceutical and Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Biopharmaceutical and Vaccines Product
Table 49. Novartis Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Biopharmaceutical and Vaccines Product
Table 54. Pfizer Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Biopharmaceutical and Vaccines Product
Table 59. Sanofi Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Biopharmaceutical and Vaccines Product
Table 64. Roche Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Abbott Company Detail
Table 67. Abbott Business Overview
Table 68. Abbott Biopharmaceutical and Vaccines Product
Table 69. Abbott Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Biogen Idec Company Detail
Table 72. Biogen Idec Business Overview
Table 73. Biogen Idec Biopharmaceutical and Vaccines Product
Table 74. Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 75. Biogen Idec Recent Development
Table 76. Regeneron Pharmaceuticals Company Detail
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product
Table 79. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Development
Table 81. Alexion Pharmaceuticals Company Detail
Table 82. Alexion Pharmaceuticals Business Overview
Table 83. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product
Table 84. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 85. Alexion Pharmaceuticals Recent Development
Table 86. Johnson and Johnson Company Detail
Table 87. Johnson and Johnson Business Overview
Table 88. Johnson and Johnson Biopharmaceutical and Vaccines Product
Table 89. Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 90. Johnson and Johnson Recent Development
Table 91. GlaxoSmithKline Company Detail
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Biopharmaceutical and Vaccines Product
Table 94. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Biopharmaceutical and Vaccines Product
Table 99. Merck Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Lonza Company Detail
Table 102. Lonza Business Overview
Table 103. Lonza Biopharmaceutical and Vaccines Product
Table 104. Lonza Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 105. Lonza Recent Development
Table 106. Boehringer Ingelheim Company Detail
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Biopharmaceutical and Vaccines Product
Table 109. Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 110. Boehringer Ingelheim Recent Development
Table 111. Rentschler Company Detail
Table 112. Rentschler Business Overview
Table 113. Rentschler Biopharmaceutical and Vaccines Product
Table 114. Rentschler Revenue in Biopharmaceutical and Vaccines Business (2019-2024) & (US$ Million)
Table 115. Rentschler Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical and Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biopharmaceutical and Vaccines Market Share by Type: 2023 VS 2030
Figure 3. Biopharmaceutical Features
Figure 4. Vaccine Production Features
Figure 5. Global Biopharmaceutical and Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Biopharmaceutical and Vaccines Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceuticals Industry Case Studies
Figure 8. Clinical Diagnosis Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Others Case Studies
Figure 11. Biopharmaceutical and Vaccines Report Years Considered
Figure 12. Global Biopharmaceutical and Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biopharmaceutical and Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biopharmaceutical and Vaccines Market Share by Region: 2023 VS 2030
Figure 15. Global Biopharmaceutical and Vaccines Market Share by Players in 2023
Figure 16. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccines as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2023
Figure 18. North America Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biopharmaceutical and Vaccines Market Share by Country (2019-2030)
Figure 20. United States Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Biopharmaceutical and Vaccines Market Share by Country (2019-2030)
Figure 24. Germany Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical and Vaccines Market Share by Region (2019-2030)
Figure 32. China Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Biopharmaceutical and Vaccines Market Share by Country (2019-2030)
Figure 40. Mexico Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical and Vaccines Market Share by Country (2019-2030)
Figure 44. Turkey Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Biopharmaceutical and Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 48. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 51. Biogen Idec Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 52. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 53. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 54. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 57. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 59. Rentschler Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
